Contact Information
Email Jesse M. Hunter, PhD
Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)
Learn more about Jesse M. Hunter
Biography
Jesse Hunter, PhD, completed his B.S. and M.S. degrees in Biochemistry at Brigham Young University followed by a Ph.D. at the University of Alabama at Birmingham in Cell Biology. He completed a Laboratory Genetics and Genomics fellowship at the Wisconsin State Laboratory of Hygiene in 2020 and recently joined Nationwide Children’s Hospital as a Clinical Laboratory Director in the Institute for Genomic Medicine. For the past eight years Dr. Hunter has focused on clinical genetic diagnostics and research. Dr. Hunter was employed by Ambry Genetics from 2016 to 2020. While at Ambry Genetics, he analyzed clinical whole exome sequencing (WES) data and performed variant analysis for cardio, cancer, and neurodevelopment next generation sequencing (NGS) panels. He also investigated the distribution of variants across the TTN gene in a large WES cohort. Prior to his work at Ambry Genetics, Dr. Hunter was carried out clinical research at the Translational Genomics Research Institute where he used WES to discover novel disease causing variants in infants and children with undiagnosed neuromuscular disorders. He also focused on the biochemistry of the Ubiquitin-like modifier-activating enzyme 1 (Uba1) and its role in X-linked spinal muscular atrophy. Dr. Hunter’s postdoctoral work was centered on Alzheimer’s disease (AD) research. At the Banner Sun Health Research Institute he investigated the role of cerebral blood flow in AD. At Eli Lilly and Company, he studied the role of ApoE4 in AD mouse models and seizures. Over the past 20 years Dr. Hunter has gained a broad range of technical experience and expertise in areas including chromosome analysis, NGS, immunohistochemistry, mouse models of neuromuscular disease, microscopy, MRI analysis, cell culture, and biochemistry.
Research
Dr. Hunter’s research is focused on advancing clinical genetic diagnostics. Publications
Mathew MT, Antoniou A, Ramesh N, Hu M, Gaither J, Mouhlas D, Hashimoto S, Humphrey M, Matthews T, Hunter JM, Reshmi S, Schultz M, Lee K, Pfau R, Cottrell C, McBride KL, Navin NE, Chaudhari BP, Leung ML. A Decade's Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties. J Mol Diagn. 2022 Jun 16;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Catts DS, Mroske C, Clark RO, Hipp SJ, Berg JM, Hunter JM, Whiteway SL. Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies. J Pediatr Hematol Oncol. 2021 May 1; 43: e517-e520.
Kasak L, Hunter JM, Udani R, Bakolitsa C, Hu Z, Adhikari AN, Babbi G, Casadio R, Gough J, Guerrero RF, Jiang Y, Joseph T, Katsonis P, Kotte S, Kundu K, Lichtarge O, Martelli PL, Mooney SD, Moult J, Pal LR, Poitras J, Radivojac P, Rao A, Sivadasan N, Sunderam U, Saipradeep VG, Yin Y, Zaucha J, Brenner SE, Meyn MS. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases. Hum Mutat. 2019 Sep; 40: 1373-1391.
Balak CD, Hunter JM, Ahearn ME, Wiley D, D'urso G, Baumbach-Reardon L. Functional characterizations of rare UBA1 variants in X-linked Spinal Muscular Atrophy. F1000Res. 2017; 6: 1636.
View More Publications
Education
Fellowship
University of Wisconsin
Date Completed: 06/30/2020
Graduate School
University of Alabama at Birmingham
Date Completed: 08/12/2006
Graduate School
Brigham Young University
Date Completed: 12/21/2001
Undergraduate School
Brigham Young University
Date Completed: 07/01/1999
Professional Experience
2020 - Present Nationwide Children’s Hospital, Clinical Laboratory Director2018 - 2020 Wisconsin State Laboratory of Hygiene, Laboratory Genetics and Genomics Fellow2016 - 2020 Ambry Genetics, Clinical Genomics Scientist2012 - 2016 Translational Genomics Research Institute, Research Assistant Professor2010 - 2016 Banner Sun Health Research Institute, Postdoctoral Fellow
Contact Information
Institute for Genomic Medicine
Email Jesse M Hunter
575 Children's CrossroadColumbus, OH 43215 (map)
Contact Information
Email Jesse M. Hunter, PhD
Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)
Learn more about Jesse M. Hunter
Biography
Jesse Hunter, PhD, completed his B.S. and M.S. degrees in Biochemistry at Brigham Young University followed by a Ph.D. at the University of Alabama at Birmingham in Cell Biology. He completed a Laboratory Genetics and Genomics fellowship at the Wisconsin State Laboratory of Hygiene in 2020 and recently joined Nationwide Children’s Hospital as a Clinical Laboratory Director in the Institute for Genomic Medicine. For the past eight years Dr. Hunter has focused on clinical genetic diagnostics and research. Dr. Hunter was employed by Ambry Genetics from 2016 to 2020. While at Ambry Genetics, he analyzed clinical whole exome sequencing (WES) data and performed variant analysis for cardio, cancer, and neurodevelopment next generation sequencing (NGS) panels. He also investigated the distribution of variants across the TTN gene in a large WES cohort. Prior to his work at Ambry Genetics, Dr. Hunter was carried out clinical research at the Translational Genomics Research Institute where he used WES to discover novel disease causing variants in infants and children with undiagnosed neuromuscular disorders. He also focused on the biochemistry of the Ubiquitin-like modifier-activating enzyme 1 (Uba1) and its role in X-linked spinal muscular atrophy. Dr. Hunter’s postdoctoral work was centered on Alzheimer’s disease (AD) research. At the Banner Sun Health Research Institute he investigated the role of cerebral blood flow in AD. At Eli Lilly and Company, he studied the role of ApoE4 in AD mouse models and seizures. Over the past 20 years Dr. Hunter has gained a broad range of technical experience and expertise in areas including chromosome analysis, NGS, immunohistochemistry, mouse models of neuromuscular disease, microscopy, MRI analysis, cell culture, and biochemistry.
Research
Dr. Hunter’s research is focused on advancing clinical genetic diagnostics. Publications
Mathew MT, Antoniou A, Ramesh N, Hu M, Gaither J, Mouhlas D, Hashimoto S, Humphrey M, Matthews T, Hunter JM, Reshmi S, Schultz M, Lee K, Pfau R, Cottrell C, McBride KL, Navin NE, Chaudhari BP, Leung ML. A Decade's Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties. J Mol Diagn. 2022 Jun 16;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Catts DS, Mroske C, Clark RO, Hipp SJ, Berg JM, Hunter JM, Whiteway SL. Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies. J Pediatr Hematol Oncol. 2021 May 1; 43: e517-e520.
Kasak L, Hunter JM, Udani R, Bakolitsa C, Hu Z, Adhikari AN, Babbi G, Casadio R, Gough J, Guerrero RF, Jiang Y, Joseph T, Katsonis P, Kotte S, Kundu K, Lichtarge O, Martelli PL, Mooney SD, Moult J, Pal LR, Poitras J, Radivojac P, Rao A, Sivadasan N, Sunderam U, Saipradeep VG, Yin Y, Zaucha J, Brenner SE, Meyn MS. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases. Hum Mutat. 2019 Sep; 40: 1373-1391.
Balak CD, Hunter JM, Ahearn ME, Wiley D, D'urso G, Baumbach-Reardon L. Functional characterizations of rare UBA1 variants in X-linked Spinal Muscular Atrophy. F1000Res. 2017; 6: 1636.
View More Publications
Education
Fellowship
University of Wisconsin
Date Completed: 06/30/2020
Graduate School
University of Alabama at Birmingham
Date Completed: 08/12/2006
Graduate School
Brigham Young University
Date Completed: 12/21/2001
Undergraduate School
Brigham Young University
Date Completed: 07/01/1999
Professional Experience
2020 - Present Nationwide Children’s Hospital, Clinical Laboratory Director2018 - 2020 Wisconsin State Laboratory of Hygiene, Laboratory Genetics and Genomics Fellow2016 - 2020 Ambry Genetics, Clinical Genomics Scientist2012 - 2016 Translational Genomics Research Institute, Research Assistant Professor2010 - 2016 Banner Sun Health Research Institute, Postdoctoral Fellow
Contact Information
Institute for Genomic Medicine
Email Jesse M Hunter
575 Children's CrossroadColumbus, OH 43215 (map)
Contact Information
Email Jesse M. Hunter, PhD
Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)
Learn more about Jesse M. Hunter
Contact Information
- Email Jesse M. Hunter, PhD
- Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)
Learn more about Jesse M. Hunter
Biography
Jesse Hunter, PhD, completed his B.S. and M.S. degrees in Biochemistry at Brigham Young University followed by a Ph.D. at the University of Alabama at Birmingham in Cell Biology. He completed a Laboratory Genetics and Genomics fellowship at the Wisconsin State Laboratory of Hygiene in 2020 and recently joined Nationwide Children’s Hospital as a Clinical Laboratory Director in the Institute for Genomic Medicine. For the past eight years Dr. Hunter has focused on clinical genetic diagnostics and research. Dr. Hunter was employed by Ambry Genetics from 2016 to 2020. While at Ambry Genetics, he analyzed clinical whole exome sequencing (WES) data and performed variant analysis for cardio, cancer, and neurodevelopment next generation sequencing (NGS) panels. He also investigated the distribution of variants across the TTN gene in a large WES cohort. Prior to his work at Ambry Genetics, Dr. Hunter was carried out clinical research at the Translational Genomics Research Institute where he used WES to discover novel disease causing variants in infants and children with undiagnosed neuromuscular disorders. He also focused on the biochemistry of the Ubiquitin-like modifier-activating enzyme 1 (Uba1) and its role in X-linked spinal muscular atrophy. Dr. Hunter’s postdoctoral work was centered on Alzheimer’s disease (AD) research. At the Banner Sun Health Research Institute he investigated the role of cerebral blood flow in AD. At Eli Lilly and Company, he studied the role of ApoE4 in AD mouse models and seizures. Over the past 20 years Dr. Hunter has gained a broad range of technical experience and expertise in areas including chromosome analysis, NGS, immunohistochemistry, mouse models of neuromuscular disease, microscopy, MRI analysis, cell culture, and biochemistry.
Biography
Jesse Hunter, PhD, completed his B.S. and M.S. degrees in Biochemistry at Brigham Young University followed by a Ph.D. at the University of Alabama at Birmingham in Cell Biology. He completed a Laboratory Genetics and Genomics fellowship at the Wisconsin State Laboratory of Hygiene in 2020 and recently joined Nationwide Children’s Hospital as a Clinical Laboratory Director in the Institute for Genomic Medicine. For the past eight years Dr. Hunter has focused on clinical genetic diagnostics and research. Dr. Hunter was employed by Ambry Genetics from 2016 to 2020. While at Ambry Genetics, he analyzed clinical whole exome sequencing (WES) data and performed variant analysis for cardio, cancer, and neurodevelopment next generation sequencing (NGS) panels. He also investigated the distribution of variants across the TTN gene in a large WES cohort. Prior to his work at Ambry Genetics, Dr. Hunter was carried out clinical research at the Translational Genomics Research Institute where he used WES to discover novel disease causing variants in infants and children with undiagnosed neuromuscular disorders. He also focused on the biochemistry of the Ubiquitin-like modifier-activating enzyme 1 (Uba1) and its role in X-linked spinal muscular atrophy. Dr. Hunter’s postdoctoral work was centered on Alzheimer’s disease (AD) research. At the Banner Sun Health Research Institute he investigated the role of cerebral blood flow in AD. At Eli Lilly and Company, he studied the role of ApoE4 in AD mouse models and seizures. Over the past 20 years Dr. Hunter has gained a broad range of technical experience and expertise in areas including chromosome analysis, NGS, immunohistochemistry, mouse models of neuromuscular disease, microscopy, MRI analysis, cell culture, and biochemistry.
Biography
Jesse Hunter, PhD, completed his B.S. and M.S. degrees in Biochemistry at Brigham Young University followed by a Ph.D. at the University of Alabama at Birmingham in Cell Biology. He completed a Laboratory Genetics and Genomics fellowship at the Wisconsin State Laboratory of Hygiene in 2020 and recently joined Nationwide Children’s Hospital as a Clinical Laboratory Director in the Institute for Genomic Medicine. For the past eight years Dr. Hunter has focused on clinical genetic diagnostics and research. Dr. Hunter was employed by Ambry Genetics from 2016 to 2020. While at Ambry Genetics, he analyzed clinical whole exome sequencing (WES) data and performed variant analysis for cardio, cancer, and neurodevelopment next generation sequencing (NGS) panels. He also investigated the distribution of variants across the TTN gene in a large WES cohort. Prior to his work at Ambry Genetics, Dr. Hunter was carried out clinical research at the Translational Genomics Research Institute where he used WES to discover novel disease causing variants in infants and children with undiagnosed neuromuscular disorders. He also focused on the biochemistry of the Ubiquitin-like modifier-activating enzyme 1 (Uba1) and its role in X-linked spinal muscular atrophy. Dr. Hunter’s postdoctoral work was centered on Alzheimer’s disease (AD) research. At the Banner Sun Health Research Institute he investigated the role of cerebral blood flow in AD. At Eli Lilly and Company, he studied the role of ApoE4 in AD mouse models and seizures. Over the past 20 years Dr. Hunter has gained a broad range of technical experience and expertise in areas including chromosome analysis, NGS, immunohistochemistry, mouse models of neuromuscular disease, microscopy, MRI analysis, cell culture, and biochemistry.
Jesse Hunter, PhD, completed his B.S. and M.S. degrees in Biochemistry at Brigham Young University followed by a Ph.D. at the University of Alabama at Birmingham in Cell Biology. He completed a Laboratory Genetics and Genomics fellowship at the Wisconsin State Laboratory of Hygiene in 2020 and recently joined Nationwide Children’s Hospital as a Clinical Laboratory Director in the Institute for Genomic Medicine. For the past eight years Dr. Hunter has focused on clinical genetic diagnostics and research. Dr. Hunter was employed by Ambry Genetics from 2016 to 2020. While at Ambry Genetics, he analyzed clinical whole exome sequencing (WES) data and performed variant analysis for cardio, cancer, and neurodevelopment next generation sequencing (NGS) panels. He also investigated the distribution of variants across the TTN gene in a large WES cohort. Prior to his work at Ambry Genetics, Dr. Hunter was carried out clinical research at the Translational Genomics Research Institute where he used WES to discover novel disease causing variants in infants and children with undiagnosed neuromuscular disorders. He also focused on the biochemistry of the Ubiquitin-like modifier-activating enzyme 1 (Uba1) and its role in X-linked spinal muscular atrophy. Dr. Hunter’s postdoctoral work was centered on Alzheimer’s disease (AD) research. At the Banner Sun Health Research Institute he investigated the role of cerebral blood flow in AD. At Eli Lilly and Company, he studied the role of ApoE4 in AD mouse models and seizures. Over the past 20 years Dr. Hunter has gained a broad range of technical experience and expertise in areas including chromosome analysis, NGS, immunohistochemistry, mouse models of neuromuscular disease, microscopy, MRI analysis, cell culture, and biochemistry.
Jesse Hunter, PhD, completed his B.S. and M.S. degrees in Biochemistry at Brigham Young University followed by a Ph.D. at the University of Alabama at Birmingham in Cell Biology. He completed a Laboratory Genetics and Genomics fellowship at the Wisconsin State Laboratory of Hygiene in 2020 and recently joined Nationwide Children’s Hospital as a Clinical Laboratory Director in the Institute for Genomic Medicine.
For the past eight years Dr. Hunter has focused on clinical genetic diagnostics and research. Dr. Hunter was employed by Ambry Genetics from 2016 to 2020. While at Ambry Genetics, he analyzed clinical whole exome sequencing (WES) data and performed variant analysis for cardio, cancer, and neurodevelopment next generation sequencing (NGS) panels. He also investigated the distribution of variants across the TTN gene in a large WES cohort. Prior to his work at Ambry Genetics, Dr. Hunter was carried out clinical research at the Translational Genomics Research Institute where he used WES to discover novel disease causing variants in infants and children with undiagnosed neuromuscular disorders. He also focused on the biochemistry of the Ubiquitin-like modifier-activating enzyme 1 (Uba1) and its role in X-linked spinal muscular atrophy. Dr. Hunter’s postdoctoral work was centered on Alzheimer’s disease (AD) research. At the Banner Sun Health Research Institute he investigated the role of cerebral blood flow in AD. At Eli Lilly and Company, he studied the role of ApoE4 in AD mouse models and seizures. Over the past 20 years Dr. Hunter has gained a broad range of technical experience and expertise in areas including chromosome analysis, NGS, immunohistochemistry, mouse models of neuromuscular disease, microscopy, MRI analysis, cell culture, and biochemistry.
Research
Dr. Hunter’s research is focused on advancing clinical genetic diagnostics. Publications
Mathew MT, Antoniou A, Ramesh N, Hu M, Gaither J, Mouhlas D, Hashimoto S, Humphrey M, Matthews T, Hunter JM, Reshmi S, Schultz M, Lee K, Pfau R, Cottrell C, McBride KL, Navin NE, Chaudhari BP, Leung ML. A Decade's Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties. J Mol Diagn. 2022 Jun 16;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Catts DS, Mroske C, Clark RO, Hipp SJ, Berg JM, Hunter JM, Whiteway SL. Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies. J Pediatr Hematol Oncol. 2021 May 1; 43: e517-e520.
Kasak L, Hunter JM, Udani R, Bakolitsa C, Hu Z, Adhikari AN, Babbi G, Casadio R, Gough J, Guerrero RF, Jiang Y, Joseph T, Katsonis P, Kotte S, Kundu K, Lichtarge O, Martelli PL, Mooney SD, Moult J, Pal LR, Poitras J, Radivojac P, Rao A, Sivadasan N, Sunderam U, Saipradeep VG, Yin Y, Zaucha J, Brenner SE, Meyn MS. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases. Hum Mutat. 2019 Sep; 40: 1373-1391.
Balak CD, Hunter JM, Ahearn ME, Wiley D, D'urso G, Baumbach-Reardon L. Functional characterizations of rare UBA1 variants in X-linked Spinal Muscular Atrophy. F1000Res. 2017; 6: 1636.
View More Publications
Research
Dr. Hunter’s research is focused on advancing clinical genetic diagnostics. Publications
Mathew MT, Antoniou A, Ramesh N, Hu M, Gaither J, Mouhlas D, Hashimoto S, Humphrey M, Matthews T, Hunter JM, Reshmi S, Schultz M, Lee K, Pfau R, Cottrell C, McBride KL, Navin NE, Chaudhari BP, Leung ML. A Decade's Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties. J Mol Diagn. 2022 Jun 16;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Catts DS, Mroske C, Clark RO, Hipp SJ, Berg JM, Hunter JM, Whiteway SL. Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies. J Pediatr Hematol Oncol. 2021 May 1; 43: e517-e520.
Kasak L, Hunter JM, Udani R, Bakolitsa C, Hu Z, Adhikari AN, Babbi G, Casadio R, Gough J, Guerrero RF, Jiang Y, Joseph T, Katsonis P, Kotte S, Kundu K, Lichtarge O, Martelli PL, Mooney SD, Moult J, Pal LR, Poitras J, Radivojac P, Rao A, Sivadasan N, Sunderam U, Saipradeep VG, Yin Y, Zaucha J, Brenner SE, Meyn MS. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases. Hum Mutat. 2019 Sep; 40: 1373-1391.
Balak CD, Hunter JM, Ahearn ME, Wiley D, D'urso G, Baumbach-Reardon L. Functional characterizations of rare UBA1 variants in X-linked Spinal Muscular Atrophy. F1000Res. 2017; 6: 1636.
View More Publications
Research
Dr. Hunter’s research is focused on advancing clinical genetic diagnostics. Publications
Mathew MT, Antoniou A, Ramesh N, Hu M, Gaither J, Mouhlas D, Hashimoto S, Humphrey M, Matthews T, Hunter JM, Reshmi S, Schultz M, Lee K, Pfau R, Cottrell C, McBride KL, Navin NE, Chaudhari BP, Leung ML. A Decade's Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties. J Mol Diagn. 2022 Jun 16;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Catts DS, Mroske C, Clark RO, Hipp SJ, Berg JM, Hunter JM, Whiteway SL. Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies. J Pediatr Hematol Oncol. 2021 May 1; 43: e517-e520.
Kasak L, Hunter JM, Udani R, Bakolitsa C, Hu Z, Adhikari AN, Babbi G, Casadio R, Gough J, Guerrero RF, Jiang Y, Joseph T, Katsonis P, Kotte S, Kundu K, Lichtarge O, Martelli PL, Mooney SD, Moult J, Pal LR, Poitras J, Radivojac P, Rao A, Sivadasan N, Sunderam U, Saipradeep VG, Yin Y, Zaucha J, Brenner SE, Meyn MS. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases. Hum Mutat. 2019 Sep; 40: 1373-1391.
Balak CD, Hunter JM, Ahearn ME, Wiley D, D'urso G, Baumbach-Reardon L. Functional characterizations of rare UBA1 variants in X-linked Spinal Muscular Atrophy. F1000Res. 2017; 6: 1636.
View More Publications
Dr. Hunter’s research is focused on advancing clinical genetic diagnostics. Publications
Mathew MT, Antoniou A, Ramesh N, Hu M, Gaither J, Mouhlas D, Hashimoto S, Humphrey M, Matthews T, Hunter JM, Reshmi S, Schultz M, Lee K, Pfau R, Cottrell C, McBride KL, Navin NE, Chaudhari BP, Leung ML. A Decade's Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties. J Mol Diagn. 2022 Jun 16;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Catts DS, Mroske C, Clark RO, Hipp SJ, Berg JM, Hunter JM, Whiteway SL. Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies. J Pediatr Hematol Oncol. 2021 May 1; 43: e517-e520.
Kasak L, Hunter JM, Udani R, Bakolitsa C, Hu Z, Adhikari AN, Babbi G, Casadio R, Gough J, Guerrero RF, Jiang Y, Joseph T, Katsonis P, Kotte S, Kundu K, Lichtarge O, Martelli PL, Mooney SD, Moult J, Pal LR, Poitras J, Radivojac P, Rao A, Sivadasan N, Sunderam U, Saipradeep VG, Yin Y, Zaucha J, Brenner SE, Meyn MS. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases. Hum Mutat. 2019 Sep; 40: 1373-1391.
Balak CD, Hunter JM, Ahearn ME, Wiley D, D'urso G, Baumbach-Reardon L. Functional characterizations of rare UBA1 variants in X-linked Spinal Muscular Atrophy. F1000Res. 2017; 6: 1636.
View More Publications
Dr. Hunter’s research is focused on advancing clinical genetic diagnostics.
Mathew MT, Antoniou A, Ramesh N, Hu M, Gaither J, Mouhlas D, Hashimoto S, Humphrey M, Matthews T, Hunter JM, Reshmi S, Schultz M, Lee K, Pfau R, Cottrell C, McBride KL, Navin NE, Chaudhari BP, Leung ML. A Decade's Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties. J Mol Diagn. 2022 Jun 16;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Catts DS, Mroske C, Clark RO, Hipp SJ, Berg JM, Hunter JM, Whiteway SL. Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies. J Pediatr Hematol Oncol. 2021 May 1; 43: e517-e520.
Kasak L, Hunter JM, Udani R, Bakolitsa C, Hu Z, Adhikari AN, Babbi G, Casadio R, Gough J, Guerrero RF, Jiang Y, Joseph T, Katsonis P, Kotte S, Kundu K, Lichtarge O, Martelli PL, Mooney SD, Moult J, Pal LR, Poitras J, Radivojac P, Rao A, Sivadasan N, Sunderam U, Saipradeep VG, Yin Y, Zaucha J, Brenner SE, Meyn MS. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases. Hum Mutat. 2019 Sep; 40: 1373-1391.
Balak CD, Hunter JM, Ahearn ME, Wiley D, D'urso G, Baumbach-Reardon L. Functional characterizations of rare UBA1 variants in X-linked Spinal Muscular Atrophy. F1000Res. 2017; 6: 1636.
View More Publications
- Mathew MT, Antoniou A, Ramesh N, Hu M, Gaither J, Mouhlas D, Hashimoto S, Humphrey M, Matthews T, Hunter JM, Reshmi S, Schultz M, Lee K, Pfau R, Cottrell C, McBride KL, Navin NE, Chaudhari BP, Leung ML. A Decade’s Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties. J Mol Diagn. 2022 Jun 16;
- Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
- Catts DS, Mroske C, Clark RO, Hipp SJ, Berg JM, Hunter JM, Whiteway SL. Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies. J Pediatr Hematol Oncol. 2021 May 1; 43: e517-e520.
- Kasak L, Hunter JM, Udani R, Bakolitsa C, Hu Z, Adhikari AN, Babbi G, Casadio R, Gough J, Guerrero RF, Jiang Y, Joseph T, Katsonis P, Kotte S, Kundu K, Lichtarge O, Martelli PL, Mooney SD, Moult J, Pal LR, Poitras J, Radivojac P, Rao A, Sivadasan N, Sunderam U, Saipradeep VG, Yin Y, Zaucha J, Brenner SE, Meyn MS. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases. Hum Mutat. 2019 Sep; 40: 1373-1391.
- Balak CD, Hunter JM, Ahearn ME, Wiley D, D’urso G, Baumbach-Reardon L. Functional characterizations of rare UBA1 variants in X-linked Spinal Muscular Atrophy. F1000Res. 2017; 6: 1636.
Education
Fellowship
University of Wisconsin
Date Completed: 06/30/2020
Graduate School
University of Alabama at Birmingham
Date Completed: 08/12/2006
Graduate School
Brigham Young University
Date Completed: 12/21/2001
Undergraduate School
Brigham Young University
Date Completed: 07/01/1999
Education
Fellowship
University of Wisconsin
Date Completed: 06/30/2020
Graduate School
University of Alabama at Birmingham
Date Completed: 08/12/2006
Graduate School
Brigham Young University
Date Completed: 12/21/2001
Undergraduate School
Brigham Young University
Date Completed: 07/01/1999
Education
Fellowship
University of Wisconsin
Date Completed: 06/30/2020
Graduate School
University of Alabama at Birmingham
Date Completed: 08/12/2006
Graduate School
Brigham Young University
Date Completed: 12/21/2001
Undergraduate School
Brigham Young University
Date Completed: 07/01/1999
Fellowship
University of Wisconsin
Date Completed: 06/30/2020
Graduate School
University of Alabama at Birmingham
Date Completed: 08/12/2006
Graduate School
Brigham Young University
Date Completed: 12/21/2001
Undergraduate School
Brigham Young University
Date Completed: 07/01/1999
Fellowship
University of Wisconsin
Date Completed: 06/30/2020
Graduate School
University of Alabama at Birmingham
Date Completed: 08/12/2006
Graduate School
Brigham Young University
Date Completed: 12/21/2001
Undergraduate School
Brigham Young University
Date Completed: 07/01/1999
Professional Experience
2020 - Present Nationwide Children’s Hospital, Clinical Laboratory Director2018 - 2020 Wisconsin State Laboratory of Hygiene, Laboratory Genetics and Genomics Fellow2016 - 2020 Ambry Genetics, Clinical Genomics Scientist2012 - 2016 Translational Genomics Research Institute, Research Assistant Professor2010 - 2016 Banner Sun Health Research Institute, Postdoctoral Fellow
Professional Experience
2020 - Present Nationwide Children’s Hospital, Clinical Laboratory Director2018 - 2020 Wisconsin State Laboratory of Hygiene, Laboratory Genetics and Genomics Fellow2016 - 2020 Ambry Genetics, Clinical Genomics Scientist2012 - 2016 Translational Genomics Research Institute, Research Assistant Professor2010 - 2016 Banner Sun Health Research Institute, Postdoctoral Fellow
Professional Experience
2020 - Present Nationwide Children’s Hospital, Clinical Laboratory Director2018 - 2020 Wisconsin State Laboratory of Hygiene, Laboratory Genetics and Genomics Fellow2016 - 2020 Ambry Genetics, Clinical Genomics Scientist2012 - 2016 Translational Genomics Research Institute, Research Assistant Professor2010 - 2016 Banner Sun Health Research Institute, Postdoctoral Fellow
2020 - Present Nationwide Children’s Hospital, Clinical Laboratory Director2018 - 2020 Wisconsin State Laboratory of Hygiene, Laboratory Genetics and Genomics Fellow2016 - 2020 Ambry Genetics, Clinical Genomics Scientist2012 - 2016 Translational Genomics Research Institute, Research Assistant Professor2010 - 2016 Banner Sun Health Research Institute, Postdoctoral Fellow
2020 - Present Nationwide Children’s Hospital, Clinical Laboratory Director
Contact Information
Institute for Genomic Medicine
Email Jesse M Hunter
575 Children's CrossroadColumbus, OH 43215 (map)
Contact Information
Institute for Genomic Medicine
Email Jesse M Hunter
575 Children's CrossroadColumbus, OH 43215 (map)
Contact Information
Institute for Genomic Medicine
Email Jesse M Hunter
575 Children's CrossroadColumbus, OH 43215 (map)
Institute for Genomic Medicine
Email Jesse M Hunter
575 Children's CrossroadColumbus, OH 43215 (map)
Email Jesse M Hunter
575 Children's CrossroadColumbus, OH 43215 (map)
Email Jesse M Hunter
575 Children's CrossroadColumbus, OH 43215 (map)
- Email Jesse M Hunter
- 575 Children’s CrossroadColumbus, OH 43215 (map)
